Decitabine and neutropenia Patient Reports February 10, 2010

Decitabine Side Effects Report #5600993-0
Decitabine side effect was reported by a Physician from ITALY on Jan 07, 2008. Male patient, 77 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: fatigue, neutropenia, pneumonitis. Decitabine dosage: 252 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5724482-8
Decitabine side effect was reported by a Physician from ITALY on Apr 17, 2008. Male patient, 77 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: fatigue, neutropenia, platelet count decreased, pneumonitis, pyrexia. Decitabine dosage: 135MG/M2 PER COURSE, EVERY SIX WEEKS : 252 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5766468-3
Decitabine side effect was reported by a Physician from ITALY on May 26, 2008. Male patient, 77 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia, pneumonia . Decitabine dosage: 135MG/M2 PER COURSE, EVERY SIX WEEKS; 252 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5460621-4
Decitabine side effect was reported by a Physician from ITALY on Sept 05, 2007. Male patient, 76 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: fatigue, nausea , neutropenia, pneumonitis, pyrexia. Decitabine dosage: unknown. Patient was hospitalized. Patient recovered.


Decitabine Side Effects Report #5729581-2
Decitabine side effect was reported by a Physician from ITALY on Apr 21, 2008. Male patient, 76 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: fatigue, nausea , neutropenia, pneumonitis. Decitabine dosage: 28 MG, IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5745848-6
Decitabine side effect was reported by a Physician from ITALY on May 07, 2008. Male patient, 76 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: blood creatinine increased, haemoglobin decreased, neutropenia, pneumonia , pneumonitis, thrombocytopenia. Decitabine dosage: 28 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized and became disabled. Patient recovered.

Decitabine Side Effects Report #5642744-X
Decitabine side effect was reported by a Physician from GERMANY on Feb 18, 2008. Female patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia, pharyngitis. Decitabine dosage: 245.7 MG, IN 1 TOTAL, INTRAVENOUS. During the same period patient was treated with METOPROLOL TARTRATE, QUINAPRIL, OXAZEPAM, DIFLUCAN, COTRIMTE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5485658-0
Decitabine side effect was reported by a Physician from ARGENTINA on Sept 17, 2007. Male patient, 68 years of age, weighting 118.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: ascites, disorientation, gastrointestinal haemorrhage, hypotension, neutropenia, thrombocytopenia. Decitabine dosage: 10 MG/M2, INTRAVENOUS. During the same period patient was treated with ALDOSTERONE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5328352-9
Decitabine side effect was reported by a Physician from TURKEY on May 07, 2007. Female patient, 64 years of age, weighting 163.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, caecitis, diarrhoea, haemoglobin decreased, haemorrhage intracranial, hypotension, liver function test abnormal, neutropenia, prothrombin time prolonged. Decitabine dosage: 15 MG/M**2; Q8H; IV. During the same period patient was treated with DEFEROXAMINE MESYLATE. Patient was hospitalized. Patient died on 03/22/2007.


Decitabine Side Effects Report #5907802-0
Decitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 17, 2008. Female patient, 62 years of age, weighting 141.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: asthenia, blood culture positive, body temperature increased, culture urine positive, gastritis haemorrhagic, melaena, neutropenia, white blood cell count decreased. Decitabine dosage: 33 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5924663-4
Decitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Sept 30, 2008. Female patient, 62 years of age, weighting 143.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: body temperature increased, culture urine positive, gastritis haemorrhagic, neutropenia, platelet count decreased. Decitabine dosage: 33 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5613385-5
Decitabine side effect was reported by a Physician from ISRAEL on Sept 16, 2007. Female patient, 59 years of age, weighting 127.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, skin haemorrhage, thrombocytopenia. Decitabine dosage: unknown. During the same period patient was treated with HEXAKAPRON. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5497131-4
Decitabine side effect was reported by a Physician from ISRAEL on Oct 08, 2007. Female patient, 56 years of age, weighting 198.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: ecthyma, gangrene, leukopenia, neutropenia, pyrexia, thrombocytopenia. Decitabine dosage: unknown. During the same period patient was treated with EXJADE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5996596-9
Decitabine side effect was reported by a Physician from PHILIPPINES on Nov 18, 2008. Male patient, 55 years of age, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: condition aggravated, lung infiltration, myelodysplastic syndrome, neutropenia, sepsis , thrombocytopenia. Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died on 11/18/2008.


Decitabine Side Effects Report #5588313-1
Decitabine side effect was reported by a Physician from ISRAEL on Dec 30, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: candidiasis, hepatic candidiasis, liver abscess, neutropenia, pancytopenia, renal abscess, skin candida, splenic abscess, systemic candida. Decitabine dosage: 30 MG, INTRAVENOUS. Patient recovered.

Decitabine Side Effects Report #5646198-9
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 18, 2008. Female patient was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: colitis, haematocrit decreased, hypotension, neutropenia, platelet count decreased, pyrexia, septic shock. Decitabine dosage: 29 MG, INTRAVENOUS. During the same period patient was treated with SODAMINT, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #4622577-3
Decitabine side effect was reported by a Health Professional from on Mar 25, 2005. Male patient, 54 years of age, weighting 183.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia. Decitabine dosage: 17 MG QD X 10 DA SUBCUTANEOUS. During the same period patient was treated with ALDESLEUKIN CHIRON CORPORATION, NORVASC, PEGFILGRASTIM. Patient recovered.

Decitabine Side Effects Report #5371366-3
Decitabine side effect was reported by a Physician from FRANCE on June 06, 2007. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: aplasia, cellulitis , exophthalmos, fungal sepsis, nasal necrosis, neutropenia, septic shock, sinusitis . Decitabine dosage: unknown. Patient died on 04/11/2007.

Decitabine Side Effects Report #5766469-5
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on May 28, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: dizziness , headache , insomnia, neutropenia, phlebitis, pyrexia, upper respiratory tract infection. Decitabine dosage: 31.2 MG, IN 1 DAY, INTRAVENOUS; 31.8 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.


Decitabine Side Effects Report #5800550-7
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on June 20, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia, phlebitis, pyrexia, thrombosis, vasculitis . Decitabine dosage: 31.2 MG, IN 1 DAY, INTRAVENOUS; 31.2 MG, IN 1 DAY, INTRAVENOUS; 31.8 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, METOCLOPRAMIDE, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5846227-3
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 07, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malaise, neutropenia, phlebitis, platelet count decreased, pyrexia, thrombosis, vasculitis . Decitabine dosage: 31.2, MG, IN 1 DAY; INTRAVENOUS, 31.8 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, METOCLOPRAMIDE, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5869314-2
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 13, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, neutropenia, phlebitis, pyrexia, thrombosis, vasculitis . Decitabine dosage: 31.2 MG, 1 IN 1 DAY, INTRAVENOUS; 31.8 MG, 1 IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5877391-8
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 27, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, neutropenia, phlebitis, vasculitis . Decitabine dosage: 31.2 MG; 31.2 MG; 31.8 MG; 31.8 MG, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, METOCLOPRAMIDE, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5887054-0
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 13, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia, phlebitis, thrombosis, vasculitis . Decitabine dosage: 31.2 MG, 1 IN 1 DAY; INTRAVENOUS, 31.8 MG, 1 IN 1 DAY; INTRAVENOUS. During the same period patient was treated with SENNA. Patient was hospitalized. Patient recovered.


Decitabine Side Effects Report #5175313-9
Decitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2006. Male patient, 75 years of age, weighting 144.4 lb, was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia. Decitabine dosage: unknown. During the same period patient was treated with ALLOPURINOL, GLIPIZIDE, LISINOPRIL, POTASSIUM CHLORIDE, FUROSEMIDE, ONDANSETRON, METOPROLOL TARTRATE, FILGRASTIM. Patient was hospitalized. Patient recovered.